Specifically, patients harboring a TET2 mutation or experiencing a loss of TET2 functionality are predisposed to an elevated risk of developing various cardiovascular pathologies, such as atherosclerosis (25), pulmonary hypertension (23), aortic valve stenosis, and heart failure (26, 27). This evidence concerns the gene TET2 and pulmonary hypertension.